TMBR
Timber Pharmaceuticals, Inc.
TMBR
TMBR
Delisted
TMBR was delisted on the 28th of November, 2023.
12 hedge funds and large institutions have $149K invested in Timber Pharmaceuticals, Inc. in 2019 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
12
Holders Change
-2
Holders Change %
-14.29%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
5
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Barclays
London,
United Kingdom
|
+$58K |
2 |
Jane Street
New York
|
+$4K |
3 |
![]()
Franklin Resources
San Mateo,
California
|
+$1.92K |
4 |
Victory Capital Management
San Antonio,
Texas
|
+$1K |
5 |
Citadel Advisors
Miami,
Florida
|
+$600 |
Top Sellers
1 |
VC
Vivo Capital
Palo Alto,
California
|
-$189K |
2 |
NFG
Nadler Financial Group
Deerfield,
Illinois
|
-$27K |
3 |
VF
Virtu Financial
New York
|
-$12.5K |
4 |
Two Sigma Investments
New York
|
-$12K |
5 |
Goldman Sachs
New York
|
-$8K |